CYLD regulates keratinocyte differentiation and skin cancer progression in humans
Por favor, use este identificador para citas ou ligazóns a este ítem:
http://hdl.handle.net/10347/22318
Ficheiros no ítem
Metadatos do ítem
Título: | CYLD regulates keratinocyte differentiation and skin cancer progression in humans |
Autor/a: | Alameda, Josefa P. Fernández Aceñero, María Jesús Moreno Maldonado, Rodolfo Navarro, Manuel Quintana, R. Page, Angustias Ramírez, Ángel Bravo Moral, Ana María Llanos Casanova, M. |
Centro/Departamento: | Universidade de Santiago de Compostela. Departamento de Anatomía, Produción Animal e Ciencias Clínicas Veterinarias |
Palabras chave: | CYLD | Keratinocyte differentiation | Skin cancer | Skin equivalents | |
Data: | 2011 |
Editor: | Nature Publishing Group |
Cita bibliográfica: | Alameda, J. P., Fernandez-Acenero, M. J., Moreno-Maldonado, R., Navarro, M., Quintana, R., Page, A., ... & Casanova, M. L. (2011). CYLD regulates keratinocyte differentiation and skin cancer progression in humans. Cell death & disease, 2(9), e208-e208. |
Resumo: | CYLD is a gene mutated in familial cylindromatosis and related diseases, leading to the development of skin appendages tumors. Although the deubiquitinase CYLD is a skin tumor suppressor, its role in skin physiology is unknown. Using skin organotypic cultures as experimental model to mimic human skin, we have found that CYLD acts as a regulator of epidermal differentiation in humans through the JNK signaling pathway. We have determined the requirement of CYLD for the maintenance of epidermal polarity, keratinocyte differentiation and apoptosis. We show that CYLD overexpression increases keratinocyte differentiation while CYLD loss of function impairs epidermal differentiation. In addition, we describe the important role of CYLD in the control of human non-melanoma skin cancer progression. Our results show the reversion of the malignancy of human squamous cell carcinomas that express increased levels of CYLD, while its functional inhibition enhances the aggressiveness of these tumors which progress toward spindle cell carcinomas. We have found that the mechanisms through which CYLD regulates skin cancer progression include the control of tumor differentiation, angiogenesis and cell survival. These findings of the role of CYLD in human skin cancer prognosis make our results relevant from a therapeutic point of view, and open new avenues for exploring novel cancer therapies |
Versión do editor: | https://doi.org/10.1038/cddis.2011.82 |
URI: | http://hdl.handle.net/10347/22318 |
DOI: | 10.1038/cddis.2011.82 |
E-ISSN: | 2041-4889 |
Dereitos: | © 2011 Macmillan Publishers Limited. This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
Coleccións
-
- APA-Artigos [117]